Theralase Technologies Inc (TLT.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 272 | 286 | 313 | 276 | 272 |
| Accounts receivable | -16 | -25 | -31 | 229 | 389 |
| Other Working Capital | 103 | -436 | -452 | -238 | -50 |
| Other Operating Activity | -3,685 | -3,898 | -4,963 | -4,298 | -5,058 |
| Operating Cash Flow | $-3,326 | $-4,073 | $-5,133 | $-4,030 | $-4,446 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -20 | -37 | -70 | -101 | -165 |
| Investing Cash Flow | $-20 | $-37 | $-70 | $-101 | $-165 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -117 | -117 | -46 | -57 | -52 |
| Common Stock Issued | 3,690 | 2,763 | 2,722 | N/A | 0 |
| Other Financing Activity | -2 | -1 | 344 | -1 | -5 |
| Financing Cash Flow | $3,571 | $2,645 | $3,020 | $-57 | $-58 |
| Beginning Cash Position | 44 | 1,509 | 3,692 | 7,880 | 12,549 |
| End Cash Position | 269 | 44 | 1,509 | 3,692 | 7,880 |
| Net Cash Flow | $225 | $-1,465 | $-2,183 | $-4,189 | $-4,668 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,326 | -4,073 | -5,133 | -4,030 | -4,446 |
| Capital Expenditure | -20 | -37 | -70 | -101 | -165 |
| Free Cash Flow | -3,346 | -4,110 | -5,203 | -4,131 | -4,611 |